Abu Dhabi hospital becomes first in region to offer innovative glaucoma treatment

Three patients at Cleveland Clinic Abu Dhabi (CCAD) have become the first in the region to receive an innovative minimally invasive treatment for glaucoma, a common eye condition where the optic nerve becomes damaged because of an increased pressure caused by fluid build-up in the front part of the eye.

The new technology is able to immediately lower eye pressure and effectively treat the progressive damage that glaucoma can cause to the optic nerve, while reducing or eliminating the reliance on medication in most patients.

The new minimally invasive PreserFlo MicroShunt procedure involves inserting a small biocompatible stent into the drainage system of the eye in order to shunt intraocular fluid and lower pressure inside the eye. This procedure enables patients to quickly recover at home. Patients can generally return to normal, non-strenuous activities within a few days, and to a normal lifestyle within a few weeks.

Dr Jason A. Goldsmith, a staff physician in the Eye Institute at CCAD, who was part of the care team for these patients, noted that glaucoma is one of the main causes of vision loss in the UAE.

“The expansion of our minimally-invasive surgical options with the introduction of this novel approach to treat glaucoma means that even patients with advanced disease can be treated safely, with minimum downtime and positive results in most cases.”

Patient shares her experience

Dubai-based Canadian expat Natavan Tapdigova was among the first patients to be treated with this new technology in November. The 55-year-old began having symptoms of blurry vision and headaches in 2018, but she was diagnosed with glaucoma in 2020.

“Not once during all my annual check-ups at other hospitals was, I informed that I should get an eye test for my pain. One morning in 2020, my symptoms became worse. Unfortunately, I still waited for four weeks before I went to see an ophthalmologist,” Natavan said.

Her doctor found her eye pressure to be very high, ranging from 40-50 mm HG, which can cause rapid vision loss. She was prescribed pressure drops and pills to lower her eye pressure, but they came with several side effects, including red and itchy eyes, as well as dryness.

“Many people recommended Cleveland Clinic Abu Dhabi to me, so I decided to see Dr Goldsmith in 2020. He confirmed the diagnosis and tweaked my pressure medications to reduce the side effects. Until earlier this year, the medication was working well to maintain the pressure in both my eyes at around 15-18 mm HG,” the HR professional said.

The disease worsened, and her eye pressure could no longer be controlled with eye drops alone. Natavan’s pressures began to creep up to 30 mm HG, and it was time to consider incisional surgical options.

Incisional surgery as a last resort